Related Experiment Videos
Augmentation of standard depression therapy.
1Department of Psychiatry, Baylor College of Medicine, Houston, Texas 77030, USA.
Clinical Therapeutics
|May 18, 2000
Summary
For patients with depression not responding to antidepressants, augmentation strategies like lithium or thyroid hormone can be effective. Other options such as buspirone offer a safe alternative for treatment-resistant depression.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- About one-third of patients experience suboptimal responses to antidepressants.
- Treatment options include switching antidepressants or augmentation therapy.
Purpose of the Study:
- To review treatment options for patients with depression and suboptimal response to antidepressants.
- To discuss augmentation strategies for treatment-resistant depression.
Main Methods:
- Review of existing literature on antidepressant augmentation.
- Analysis of controlled clinical trials and case reports.
Main Results:
- Lithium and thyroid hormone augmentation are effective in about half of antidepressant-resistant cases.
- Central nervous system stimulants may augment antidepressant activity but have abuse potential.
- Pindolol may accelerate clinical response in some patients.
Conclusions:
- Lithium and thyroid hormone are effective augmentation options for major depressive disorder.
- Buspirone presents a safe and tolerable option for antidepressant augmentation due to its anxiolytic effects.